Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 59 out of 100. Vascular contributions

Topic: Genetics and APOE

Background Vascular dementia (VaD) is a complex cognitive disorder resulting from the interplay of vascular and genetic elements. Methylenetetrahydrofolate reductase ( MTHFR ) variants may influence homocysteine metabolism and cerebrovascular injury, but data from Indonesian patients with VaD remain limited. This study aimed to characterize coding-region MTHFR variants in an Indonesian VaD cohort and explore differences in cognitive performance and dementia severity according to common variant carrier status. Methods This exploratory cross-sectional study included 17 patients who fulfilled the NINDS–AIREN criteria for VaD. Cognitive performance and dementia severity were assessed using the Montreal Cognitive Assessment–Indonesian Version (MoCA-INA) and the global Clinical Dementia Rating (CDR), respectively. The coding exons of MTHFR were amplified by polymerase chain reaction and analyzed using Sanger sequencing. Identified variants were annotated using standard genomic databases and in-silico prediction tools. Exploratory comparisons were performed according to rs1801133 and rs1801131 carrier status. Results Seven coding variants were identified across exons 2, 3, 5, 7, 8, and 12, comprising three synonymous and four missense variants. rs1801131 and rs1801133 were detected in 4 of 17 and 3 of 17 participants, respectively. rs4846051 was identified in all 16 participants with an evaluable sequence at that locus. No statistically significant differences in MoCA-INA or global CDR scores were observed between carriers and non-carriers of rs1801133 or rs1801131. However, estimates were imprecise because of the small carrier groups. Conclusion Multiple MTHFR coding variants were identified in this small Indonesian VaD cohort. No statistically detectable genotype–phenotype differences were observed, although the limited sample size and absence of a control group preclude conclusions regarding VaD susceptibility or clinically meaningful associations. Larger controlled studies integrating homocysteine, folate status, and standardized neuroimaging are warranted.

Key findings

Study details

How this study scored 59/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record left out, no data; Study design 4 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 1 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited left out, no data; Citations per year left out, no data; Impact for its field and year left out, no data; Cited by studies here left out, no data; Still being cited left out, no data; Senior author's track record left out, no data; Institution's track record left out, no data; Multi-centre collaboration left out, no data; Indexed in PubMed 1 of 2; Free to read 0 of 2. 34 of the 58 points it could be judged on, which is 59 of 100. Total 59 of 100.34 of the 58 points we could judge = 59 of 100

Published in a peer-reviewed journal, and it is a snapshot of people at one point in time. Scored zero for effect reported and randomised / blinded because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multi-centre collaboration, so those were left out: it earned 34 of the 58 points we could judge it on, which is 59 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (F1000Res)
Journal's citation record — / 4 No journal record from OpenAlex — left out of this score
Study design 4 / 12 A snapshot of people at one point in time
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 1 / 4 17 participants
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited — / 7 No citation count (not found in OpenAlex) — left out of this score
Citations per year — / 5 No citation count or no year — left out of this score
Impact for its field and year — / 6 No field-weighted citation impact (OpenAlex has none yet) — left out of this score
Cited by studies here — / 6 Not yet checked against this library's citation graph — left out of this score
Still being cited — / 4 No yearly citation counts — left out of this score
Senior author's track record — / 4 Senior author's record not available — left out of this score
Institution's track record — / 3 No institution listed in OpenAlex — left out of this score
Multi-centre collaboration — / 3 Institutions not listed — left out of this score
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 0 / 2 Behind a paywall — scores zero
Points 34 / 58 Scored on 11 of 20 parts. We have no data for the rest, so they are left out: 34 of the 58 points we could judge it on is 59 out of 100.
Total 59 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

APA 7th

Yulianti, P., Fitrah, Y. A., Soraya, G. V., Jannah, A. R., Muis, A., Tammasse, J., et al. (2026). Characterization of MTHFR Coding Variants in Indonesian Patients With Vascular Dementia: An Exploratory Sequencing Study. F1000Res. https://doi.org/10.12688/f1000research.187866.1

Vancouver

Yulianti P, Fitrah YA, Soraya GV, Jannah AR, Muis A, Tammasse J, et al. Characterization of MTHFR Coding Variants in Indonesian Patients With Vascular Dementia: An Exploratory Sequencing Study. F1000Res. 2026. doi:10.12688/f1000research.187866.1.

BibTeX

@article{yulianti2026-5c166fcb,
  author  = {Yulianti, P. and Fitrah, Y. A. and Soraya, G. V. and Jannah, A. R. and Muis, A. and Tammasse, J. and Bahar, A. and Hara, N. and others},
  title   = {{Characterization of MTHFR Coding Variants in Indonesian Patients With Vascular Dementia: An Exploratory Sequencing Study}},
  journal = {F1000Res},
  year    = {2026},
  doi     = {10.12688/f1000research.187866.1},
  url     = {https://doi.org/10.12688/f1000research.187866.1}
}

Related studies in Vascular contributions

Similar studies

More on Vascular contributions

See all studies in Vascular contributions →